Results for this period
Interim period (second quarter)1 January 2026–30 June 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Advertising revenue declined because monetization was suspended for certain video distribution channels. This was partly offset by growth in the medical corporation-facing business through new adoptions of website production services and the Echo Video Center, renewals of existing Baby Pad series contracts, and expert- and physician-supervised advertising.
No applicable matters ("There are no applicable matters")
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥960 million (YoY +4.3%) |
| Operating profit | ¥81 million (YoY -18.4%) |
| Ordinary income | ¥77 million (YoY -18.8%) |
| Profit attributable to owners of the parent | ¥44 million (YoY -23.9%) |
| Net income per share | ¥50.25 |
| Equity ratio | End of the current fiscal period 48.8 / End of previous period 39.8 |
| Total assets | ¥1,561 million |
| Net assets | ¥779 million |
| Cash flows from operating activities | ¥72,687 thousand |
| Cash flows from investing activities | ¥-35,618 thousand |
| Cash flows from financing activities | ¥-142,821 thousand |
| Cash and cash equivalents at end of period | ¥614,330 thousand |
| Full-year earnings forecast | Net Sales ¥1,838 million (YoY -4.6%) / Operating profit ¥111 million (YoY -47.7%) / Ordinary income ¥101 million (YoY -50.3%) / Net income ¥70 million (YoY +58.3%) |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Segment revenue | Media Business ¥747,157 thousand, Business serving medical corporations ¥213,675 thousand |
| Segment profit | Media Business ¥156,507 thousand, Business serving medical corporations ¥66,011 thousand |
| Depreciation and amortization | ¥28,035 thousand |
| Disclosure regarding the going concern assumption | No applicable matters ("There are no applicable matters") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | By 10 August 2026, monetization had resumed for most of the affected channels whose monetization had been suspended. The company continues to address certain channels, but the impact is limited and the suspension of monetization has been largely resolved. Advertising revenue is expected to recover going forward, but the full-year earnings forecast remains unchanged because actual results have not yet been confirmed. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (audience: Not disclosed) |
| Issued Shares at Period-End | 941,700 |
| Treasury Shares at Period-End | 50,948 |
| Factors Behind Changes in Business Performance | Advertising revenue declined because monetization was suspended for certain video distribution channels. This was partly offset by growth in the medical corporation-facing business through new adoptions of website production services and the Echo Video Center, renewals of existing Baby Pad series contracts, and expert- and physician-supervised advertising. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company was significantly affected by the suspension of monetization for certain video distribution channels on a third-party-operated video distribution platform. Meanwhile, the medical corporation-facing business grew through the continuation and new adoption of existing services, while the media business also expanded its expert- and physician-supervised advertising offering.